Although upregulation of PPAR γ has been reported to be beneficial in the context of preventing osteoarthritis and arthritis, the PPAR-independent mechanism contribution to the anticatabolic potency of the PPAR agonists may be in good agreement with the absence of any relationship between the polymorphism PPARγ or the severity of osteoarthritis [45]. This evidence concerns the gene PPARG and arthritic joint disease.